Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal targeted brain delivery of sumatriptan for acute migraine attacks
IRCT20180120038450N4Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of sumatriptan in migraine, sponsored by Kermanshah University of Medical Sciences. Started Feb 2022; status: completed.
02
Drugs
sumatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on IRCT20180120038450N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180120038450N4.